Clinical Trial Update: The Synchronized Trial on Expectant Mothers With Depressive Symptoms by Omega-3 PUFAs (SYNCHRO) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for SYNCHRO investigating omega-3 polyunsaturated fatty acids in pregnant women with depressive symptoms; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder
• Pregnancy-related Depression

Drugs mentioned

• Omega-3 polyunsaturated fatty acids (omega-3 polyunsaturated fatty acids)

Snippet

Sponsor: Tokyo Medical University | Conditions: Pregnancy, Depression | Phase 3 | Status: COMPLETED